ZA200108051B - C7 carbonate substituted taxanes as antitumor agents. - Google Patents

C7 carbonate substituted taxanes as antitumor agents.

Info

Publication number
ZA200108051B
ZA200108051B ZA200108051A ZA200108051A ZA200108051B ZA 200108051 B ZA200108051 B ZA 200108051B ZA 200108051 A ZA200108051 A ZA 200108051A ZA 200108051 A ZA200108051 A ZA 200108051A ZA 200108051 B ZA200108051 B ZA 200108051B
Authority
ZA
South Africa
Prior art keywords
antitumor agents
carbonate substituted
substituted taxanes
taxanes
carbonate
Prior art date
Application number
ZA200108051A
Other languages
English (en)
Inventor
Robert A Holton
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of ZA200108051B publication Critical patent/ZA200108051B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA200108051A 2000-02-02 2001-10-01 C7 carbonate substituted taxanes as antitumor agents. ZA200108051B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17967100P 2000-02-02 2000-02-02

Publications (1)

Publication Number Publication Date
ZA200108051B true ZA200108051B (en) 2003-12-01

Family

ID=22657501

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108051A ZA200108051B (en) 2000-02-02 2001-10-01 C7 carbonate substituted taxanes as antitumor agents.

Country Status (25)

Country Link
US (3) US6780879B2 (hu)
EP (1) EP1165552A1 (hu)
JP (1) JP2003522170A (hu)
KR (1) KR20010112395A (hu)
CN (1) CN1362958A (hu)
AU (1) AU776122B2 (hu)
BG (1) BG64890B1 (hu)
BR (1) BR0104351A (hu)
CA (1) CA2368540A1 (hu)
CZ (1) CZ20013429A3 (hu)
GE (1) GEP20043226B (hu)
HK (1) HK1047934A1 (hu)
HU (1) HUP0200756A3 (hu)
IL (1) IL145637A0 (hu)
MX (1) MXPA01009906A (hu)
NO (1) NO20014755L (hu)
NZ (1) NZ514380A (hu)
PL (1) PL350315A1 (hu)
RO (1) RO121271B1 (hu)
RU (1) RU2265019C2 (hu)
SK (1) SK13702001A3 (hu)
TR (1) TR200102857T1 (hu)
UA (1) UA74331C2 (hu)
WO (1) WO2001057030A1 (hu)
ZA (1) ZA200108051B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010112395A (ko) * 2000-02-02 2001-12-20 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서의 c7 카르보네이트 치환된 탁산
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
CN100522955C (zh) 2002-08-02 2009-08-05 伊缪诺金公司 含有新型强效紫杉烷的细胞毒性剂及其治疗用途
PE20050693A1 (es) * 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
US20060189679A1 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C(10)エチルエステルおよびc(10)シクロプロピルエステル置換タキサン

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5350866A (en) 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
ES2230790T3 (es) 1992-01-15 2005-05-01 E.R. SQUIBB & SONS, INC. Procedimientos enzimaticos para la resolucion de mezclas enantiomericas de compuestos utiles como intermedios en la preparacion de taxanos.
FR2687150B1 (fr) 1992-02-07 1995-04-28 Rhone Poulenc Rorer Sa Procede de preparation de derives du taxane.
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5698712A (en) 1992-03-06 1997-12-16 Indena S.P.A. Baccatine III derivatives
US5939561A (en) 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
US5319112A (en) 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
US5470866A (en) 1992-08-18 1995-11-28 Virginia Polytechnic Institute And State University Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
CA2111527C (en) 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
DE69433297T2 (de) * 1993-02-05 2004-10-21 Bryn Mawr College Bryn Mawr Synthese von taxol, seinen analogen und intermediaten mit variablen a-ring seitenketten
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
US5475011A (en) 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
EP0703909B1 (en) 1993-06-11 2000-04-26 PHARMACIA & UPJOHN COMPANY Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
CA2129288C (en) 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
US5622986A (en) * 1993-10-20 1997-04-22 Enzon, Inc. 2'-and/or 7-substituted taxanes
US5824701A (en) * 1993-10-20 1998-10-20 Enzon, Inc. Taxane-based prodrugs
FR2711369B1 (fr) 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
AU4133096A (en) 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
US5801191A (en) * 1995-06-01 1998-09-01 Biophysica Foundation Taxoids
TW354293B (en) 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
IL126856A0 (en) 1996-05-06 1999-09-22 Univ Florida State 1-Deoxy baccatin iii 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
PL350028A1 (en) * 2000-02-02 2002-10-21 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
KR20010112395A (ko) * 2000-02-02 2001-12-20 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서의 c7 카르보네이트 치환된 탁산
JP2003521545A (ja) * 2000-02-02 2003-07-15 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 改良された溶解性を有するタキサン製剤
IL145635A0 (en) 2000-02-02 2002-06-30 Univ Florida State Res Found Taxane formulations having improved solubility

Also Published As

Publication number Publication date
US20040138267A1 (en) 2004-07-15
PL350315A1 (en) 2002-12-02
BG64890B1 (bg) 2006-08-31
US20050165051A1 (en) 2005-07-28
EP1165552A1 (en) 2002-01-02
MXPA01009906A (es) 2003-07-28
US20020065304A1 (en) 2002-05-30
US7226944B2 (en) 2007-06-05
CZ20013429A3 (cs) 2002-04-17
JP2003522170A (ja) 2003-07-22
HK1047934A1 (zh) 2003-03-14
BR0104351A (pt) 2002-01-02
NO20014755D0 (no) 2001-10-01
AU3479301A (en) 2001-08-14
HUP0200756A2 (hu) 2002-07-29
WO2001057030A1 (en) 2001-08-09
CA2368540A1 (en) 2001-08-09
US6992104B2 (en) 2006-01-31
KR20010112395A (ko) 2001-12-20
RO121271B1 (ro) 2007-02-28
IL145637A0 (en) 2002-06-30
HUP0200756A3 (en) 2005-02-28
TR200102857T1 (tr) 2002-06-21
NO20014755L (no) 2001-11-29
RU2265019C2 (ru) 2005-11-27
US6780879B2 (en) 2004-08-24
SK13702001A3 (sk) 2002-06-04
NZ514380A (en) 2005-03-24
UA74331C2 (uk) 2005-12-15
BG105966A (en) 2002-07-31
AU776122B2 (en) 2004-08-26
GEP20043226B (en) 2004-04-26
CN1362958A (zh) 2002-08-07

Similar Documents

Publication Publication Date Title
MXPA01009901A (es) Taxanos sustituidos con ester en c7 como agentes antitumor.
ZA200205479B (en) Novel biarylcarboxamides.
ZA200300793B (en) Substituted-triazolopyrimidines as anticancer agents.
MXPA03007093A (es) Nueva composicion.
MXPA03002410A (es) 4-amino-quinazolinas.
EG23262A (en) Delta -pyrrolines.
HK1056872A1 (en) Indoloquinazolinones.
MXPA03007693A (es) Composicion para la piel.
MXPA03004993A (es) Composiciones de policarbonato.
MXPA03001591A (es) Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal.
MXPA03001877A (es) 2-guanidin-4-arilquinazolinas.
MXPA03001991A (es) Novedosas arilalcano-sulfonamidas.
MXPA03002668A (es) Guanidinas de sulfonilo.
MXPA03005714A (es) Sulfamidotienopirimidinas.
EG23378A (en) Composition.
MXPA03001269A (es) Nuevos derivados de aminociclohexano.
MXPA03002411A (es) 4-amino-quinazolinas.
HK1053472A1 (en) C10 carbonate substituted taxanes as antitumor agents.
ZA200108051B (en) C7 carbonate substituted taxanes as antitumor agents.
MXPA03003861A (es) Alquildiaminas sustituidas como inhibidores de plasmepsina o proteasas relacionadas.
MXPA03005494A (es) Benzoilpiridazinas.
MXPA01000464A (es) Composicion.
HK1061560A1 (en) Triazolo-epothilones.
MXPA03008077A (es) Composicion humedecedora para la piel..
HUP0200752A2 (en) C7 carbamoyloxy substituted taxanes as antitumor agents